Contact lenses
The latest developments from within the contact lens sector
-
As a survey suggests over half of parents polled did not know there are long-term risks of myopia, CooperVision’s new campaign will aim to increase awareness of myopia and how its progression can be slowed
-
The orthokeratology contact lenses received European approval for slowing the progression of myopia
-
The Acuvue Abiliti Overnight Therapeutic Lenses are expected to be available in the US by the end of 2021
-
Through the strategic collaboration, the companies aim to expand the availability of Menicon products developed to manage the progression of myopia
-
Eye care practitioners spoke to OT about the importance of managing myopia in practice
-
The first in a new family of contact lenses contains the amino acid tyrosine, aiming to correct vision as well as promoting the healthy development of the eye for children and young adults
-
CooperVision is pleased to launch the Brilliant Futures™ Myopia Management Programme, featuring the innovative MiSight® 1 day contact lenses.
-
The company suggests the CE mark approval will provide greater confidence for parents
-
The Brilliant Futures programme is now available in the UK, featuring tools to equip and support practices in myopia management
-
The US Food and Drug Administration has approved the use of MiSight to slow the progression of myopia in children aged between eight and 12